← Back to Search

Connective Tissue Allograft

ActiveMatrix for Rotator Cuff Repair

N/A
Waitlist Available
Led By Eric F Berkman, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 4weeks, 3 months, 6 months 9 months, and 12 months
Awards & highlights

Study Summary

This trial looks at how a new graft helps heal and improve shoulder function after rotator cuff repair surgery.

Who is the study for?
This trial is for adults with a specific type of shoulder injury called a full-thickness rotator cuff tear, who have tried physical therapy or exercises without success. They must be able to follow the study's procedures and attend all follow-ups. People can't join if they've had certain other shoulder issues, recent surgery on that shoulder, are involved in litigation related to injuries, have chronic pain disorders like fibromyalgia, substance abuse problems, or women who are pregnant or not using contraception.Check my eligibility
What is being tested?
The study tests how well ActiveMatrix® graft helps heal and improve function after rotator cuff repair surgery compared to just saline injection (standard care). Participants will receive one of two different doses of ActiveMatrix® or a saline injection during their surgery.See study design
What are the potential side effects?
While the side effects aren't specified here, similar treatments may cause discomfort at the injection site, swelling, infection risk increase around the operated area and possible allergic reactions to materials used.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 4weeks, 3 months, 6 months 9 months, and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 4weeks, 3 months, 6 months 9 months, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Sugaya score as measured by Magnetic Resonance Imaging (MRI)
Secondary outcome measures
Change in pain and functional disability as assessed by the Shoulder Pain and Disability Index (SPADI)
Change in pain intensity as assessed by the Visual Analog Scale (VAS)
Change in range of motion as assessed by the Passive Range of Motion (PROM) assessment using a goniometer
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: ActiveMatrix® Dosage BExperimental Treatment1 Intervention
Group II: ActiveMatrix® Dosage AExperimental Treatment1 Intervention
Group III: Saline InjectionPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
903 Previous Clinical Trials
320,917 Total Patients Enrolled
Skye BiologicsUNKNOWN
1 Previous Clinical Trials
275 Total Patients Enrolled
Eric F Berkman, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

ActiveMatrix® (Connective Tissue Allograft) Clinical Trial Eligibility Overview. Trial Name: NCT05894265 — N/A
Rotator Cuff Tears Research Study Groups: ActiveMatrix® Dosage A, ActiveMatrix® Dosage B, Saline Injection
Rotator Cuff Tears Clinical Trial 2023: ActiveMatrix® Highlights & Side Effects. Trial Name: NCT05894265 — N/A
ActiveMatrix® (Connective Tissue Allograft) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05894265 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment stage of this clinical trial still active?

"According to the info on clinicaltrials.gov, this trial is no longer accepting candidates. The study was first published in June 5th 2023 and has not been updated since May 30th 2023. However, there are a plethora of other medical trials that currently need participants right now with 114 registered so far."

Answered by AI

Does this experiment provide opportunities for seniors to participate?

"Candidates who are 18 years of age or older, but not beyond their 75th birthday can take part in this clinical trial."

Answered by AI

Who has the opportunity to participate in this medical experiment?

"Admittance to this particular trial necessitates participants have a torn rotator cuff and are aged 18-75. Currently, there remain 60 spaces for enrolment in the study."

Answered by AI
~34 spots leftby Jun 2025